SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-20-264761
Filing Date
2020-10-06
Accepted
2020-10-06 16:25:30
Documents
6

Document Format Files

Seq Description Document Type Size
1 F-3 d18314df3.htm F-3 585391
2 EX-1.2 d18314dex12.htm EX-1.2 242750
3 EX-5.1 d18314dex51.htm EX-5.1 55882
4 EX-23.1 d18314dex231.htm EX-23.1 1667
5 GRAPHIC g18314g32e42.jpg GRAPHIC 46442
6 GRAPHIC g18314g55c63.jpg GRAPHIC 51980
  Complete submission text file 0001193125-20-264761.txt   1018179
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-249341 | Film No.: 201227002
SIC: 2834 Pharmaceutical Preparations